Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes

Ajayi, A.; Cervi, P.

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes

Issue Date

2026

Our author(s)

Ajayi, A.

Cervi, P.

Department

Haematology

Keywords

Genetics , Haematology , Oncology

Language

en

Publisher

Nature Portfolio

ISSN

0887-692
1476-5551

Type

article

Citation

Gagnon, L.L., Duminuco, A., Stagno, F., Sobas, M., Fominykh, M., Virchis, A., Nicolin, F-E., Hildt, J., Bentley, H., Godfrey, A., Shih, L-Y., Chee, A., Mead, A., Lewandowski, K., Sobieralski, P., Hannah, G., Reyal, Y., Cummin, T., Piszcz, J., Yip, K., Frewin, R., Narayanan, S., Rahman, D., Ajayi, A., Cervi, P., Byrne, J., Taylor, T., Lebowa, W., Pavlu, J., Arami, S., Ceesay, M., Chraniuk, D., Delage, R., Condorelli, A., Santana, C., Radia, D., de Lavallade, H., Milojkovic, D., Harrison, C. & Harrington, P. 2026. Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes. Leukemia, Mar 27, (Online ahead of print).